dexmedetomidine has been researched along with casticin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Alloush, MH; El-Feraly, FS; Galal, AM; McPhail, AT; Mossa, JS; Muhammed, I; Orabi, KY | 1 |
Chen, X; Chen, Y; Guo, Y; Kan, XX; Kmoníèková, E; Li, Q; Li, YJ; Liu, XC; Wang, YJ; Weng, XG; Yang, L; Yang, Q; Zhang, D; Zhu, XX; Zídek, Z | 1 |
Gaafary, ME; Hafner, S; Huber, R; Lang, SJ; Paetz, C; Schmidt, CQ; Schmiech, M; Simmet, T; Steinborn, C; Syrovets, T; Werner, K | 1 |
Fu, C; Qiu, F; Wang, M; Zhang, K | 1 |
4 other study(ies) available for dexmedetomidine and casticin
Article | Year |
---|---|
New eudesmane sesquiterpenes from Plectranthus cylindraceus.
Topics: Anti-Infective Agents; Crystallography, X-Ray; Lamiaceae; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Sesquiterpenes | 2000 |
Flavonoids casticin and chrysosplenol D from Artemisia annua L. inhibit inflammation in vitro and in vivo.
Topics: Animals; Artemisia annua; Dermatitis; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Edema; Flavones; Flavonoids; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Male; Mice; Mice, Inbred ICR | 2015 |
Antitumor activity of an Artemisia annua herbal preparation and identification of active ingredients.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Artemisia annua; Artemisinins; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Female; Flavones; Flavonoids; Humans; Leukocytes, Mononuclear; Lung Neoplasms; Mice; Mice, Nude; Plant Extracts; Xenograft Model Antitumor Assays | 2019 |
Casticin and chrysosplenol D from Artemisia annua L. induce apoptosis by inhibiting topoisomerase IIα in human non-small-cell lung cancer cells.
Topics: Apoptosis; Artemisia annua; Carcinoma, Non-Small-Cell Lung; DNA Topoisomerases, Type II; Flavones; Flavonoids; Humans; Lung Neoplasms; Molecular Docking Simulation | 2022 |